Treace Medical Concepts (TMCI) Operating Expenses (2020 - 2026)

Treace Medical Concepts (TMCI) has 7 years of Operating Expenses data on file, last reported at $54.6 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses fell 5.05% year-over-year to $54.6 million; the trailing twelve-month figure through Mar 2026 stood at $221.0 million (changed 0.21% YoY), and the FY2025 full-year result was $223.9 million, changed 0.02% from the prior year.
• Operating Expenses for Q1 2026 stood at $54.6 million, down from $56.3 million in the prior quarter.
• Across five years, Operating Expenses topped out at $59.9 million in Q1 2024 and bottomed at $32.0 million in Q1 2022.
• The 5-year median for Operating Expenses is $54.6 million (2026), against an average of $50.4 million.
• The widest annual swing landed in 2022, when Operating Expenses surged 90.76%; it then dropped 5.05% in 2026.
• A 5-year view of Operating Expenses shows it stood at $44.2 million in 2022, then soared by 30.01% to $57.5 million in 2023, then dropped by 3.21% to $55.7 million in 2024, then grew by 1.15% to $56.3 million in 2025, then dropped by 3.11% to $54.6 million in 2026.
• The last three Operating Expenses figures came in at $54.6 million (Q1 2026), $56.3 million (Q4 2025), and $55.4 million (Q3 2025), per Business Quant data.

Peer Comparison